HuGE Literature Finder
Records 1-30
|
Gene Panel Testing in Hereditary Breast Cancer.
Archives of Iranian medicine 2020 Mar 23 (3): 155-162. Rostami Parvin, Zendehdel Kazem, Shirkoohi Reza, Ebrahimi Elmira, Ataei Mitra, Imanian Hashem, Najmabadi Hossein, Akbari Mohammad Reza, Sanati Mohammad Hosse |
|
Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients.
Clinical biochemistry 2019 Nov . Rodríguez-Balada Marta, Roig Bàrbara, Melé Mireia, Albacar Cinta, Serrano Sara, Salvat Mònica, Querol Montserrat, Borràs Joan, Martorell Lourdes, Gumà Jos |
|
Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing.
Breast cancer research and treatment 2019 Sep . Scarpitta R, Zanna I, Aretini P, Gambino G, Scatena C, Mei B, Ghilli M, Rossetti E, Roncella M, Congregati C, Bonci F, Naccarato A G, Palli D, Caligo M |
|
RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.
International journal of cancer 2018 Oct 143 (8): 1935-1942. Fan Cong, Zhang Juan, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xie Yunt |
|
Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan.
Breast cancer (Tokyo, Japan) 2018 May 25 (3): 350-355. Khan Rabbia Tariq, Siddique Ayesha, Shahid Naeem, Khokher Samina, Fatima War |
|
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population.
Hereditary cancer in clinical practice 2018 16 12. Maksimenko J, Irmejs A, Trofimovi?s G, B?rzi?a D, Skuja E, Purkalne G, Miklaševi?s E, Gardovskis |
|
Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families.
Cancer medicine 2018 01 7 (1): 46-55. Coppa Anna, Nicolussi Arianna, D'Inzeo Sonia, Capalbo Carlo, Belardinilli Francesca, Colicchia Valeria, Petroni Marialaura, Zani Massimo, Ferraro Sergio, Rinaldi Christian, Buffone Amelia, Bartolazzi Armando, Screpanti Isabella, Ottini Laura, Giannini Giusep |
|
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
JAMA oncology 2017 Sep 3 (9): 1190-1196. Couch Fergus J, Shimelis Hermela, Hu Chunling, Hart Steven N, Polley Eric C, Na Jie, Hallberg Emily, Moore Raymond, Thomas Abigail, Lilyquist Jenna, Feng Bingjian, McFarland Rachel, Pesaran Tina, Huether Robert, LaDuca Holly, Chao Elizabeth C, Goldgar David E, Dolinsky Jill |
|
Next-Generation Sequencing Reveals a Nonsense Mutation (p.Arg364Ter) in MRE11A Gene in an Indian Patient with Familial Breast Cancer.
Breast care (Basel, Switzerland) 2017 May 12 (2): 114-116. Sharma Bhai Pratibha, Sharma Deepak, Saxena Renu, Verma Ishwar |
|
Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway.
International journal of molecular sciences 2017 Feb 18 (2): . van der Merwe Nicole, Peeters Armand V, Pienaar Fredrieka M, Bezuidenhout Juanita, van Rensburg Susan J, Kotze Maritha |
|
Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians.
Carcinogenesis 2017 05 38 (5): 511-518. Han Mi-Ryung, Zheng Wei, Cai Qiuyin, Gao Yu-Tang, Zheng Ying, Bolla Manjeet K, Michailidou Kyriaki, Dennis Joe, Wang Qin, Dunning Alison M, Brennan Paul, Chen Shou-Tung, Choi Ji-Yeob, Hartman Mikael, Ito Hidemi, Lophatananon Artitaya, Matsuo Keitaro, Miao Hui, Muir Kenneth, Sangrajrang Suleeporn, Shen Chen-Yang, Teo Soo Hwang, Tseng Chiu-Chen, Wu Anna H, Yip Cheng Har, Kang Daehee, Xiang Yong-Bing, Easton Douglas F, Shu Xiao-Ou, Long Jiro |
|
Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
Breast cancer research and treatment 2017 01 161 (1): 95-102. Kim Haeyoung, Cho Dae-Yeon, Choi Doo Ho, Oh Mijin, Shin Inkyung, Park Won, Huh Seung Jae, Nam Seok Jin, Lee Jeong Eon, Kim Seok W |
|
The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.
PloS one 2017 12 (9): e0185615. Sung Pi-Lin, Wen Kuo-Chang, Chen Yi-Jen, Chao Ta-Chung, Tsai Yi-Fang, Tseng Ling-Ming, Qiu Jian-Tai Timothy, Chao Kuan-Chong, Wu Hua-Hsi, Chuang Chi-Mu, Wang Peng-Hui, Huang Chi-Ying |
|
Whole-exome sequencing of Finnish hereditary breast cancer families.
European journal of human genetics : EJHG 2016 Oct . Määttä Kirsi, Rantapero Tommi, Lindström Anna, Nykter Matti, Kankuri-Tammilehto Minna, Laasanen Satu-Leena, Schleutker Johan |
|
Reevaluation of RINT1 as a breast cancer predisposition gene.
Breast cancer research and treatment 2016 Sep 159 (2): 385-92. Li Na, Thompson Ella R, Rowley Simone M, McInerny Simone, Devereux Lisa, Goode David, Investigators LifePool, Wong-Brown Michelle W, Scott Rodney J, Trainer Alison H, Gorringe Kylie L, James Paul A, Campbell Ian |
|
Germline mutations of the DNA repair pathways in uterine serous carcinoma.
Gynecologic oncology 2016 Apr 141 (1): 101-7. Frimer Marina, Levano Kelly S, Rodriguez-Gabin Alicia, Wang Yanhua, Goldberg Gary L, Horwitz Susan Band, Hou June |
|
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer.
Oncotarget 2016 Jan . Lin Po-Han, Kuo Wen-Hung, Huang Ai-Chu, Lu Yen-Shen, Lin Ching-Hung, Kuo Sung-Hsin, Wang Ming-Yang, Liu Chun-Yu, Cheng Fiona Tsui-Fen, Yeh Ming-Hsin, Li Huei-Ying, Yang Yu-Hsuan, Hsu Yu-Hua, Fan Sheng-Chih, Li Long-Yuan, Yu Sung-Liang, Chang King-Jen, Chen Pei-Lung, Ni Yen-Hsuan, Huang Chiun-She |
|
Multigene testing of moderate-risk genes: be mindful of the missense.
Journal of medical genetics 2016 06 53 (6): 366-76. Young E L, Feng B J, Stark A W, Damiola F, Durand G, Forey N, Francy T C, Gammon A, Kohlmann W K, Kaphingst K A, McKay-Chopin S, Nguyen-Dumont T, Oliver J, Paquette A M, Pertesi M, Robinot N, Rosenthal J S, Vallee M, Voegele C, Hopper J L, Southey M C, Andrulis I L, John E M, Hashibe M, Gertz J, , Le Calvez-Kelm F, Lesueur F, Goldgar D E, Tavtigian S |
|
Detection of novel germline mutations for breast cancer in non-BRCA1/2 families.
The FEBS journal 2015 Sep 282 (17): 3424-37. Aloraifi Fatima, McDevitt Trudi, Martiniano Rui, McGreevy Jonah, McLaughlin Russell, Egan Chris M, Cody Nuala, Meany Marie, Kenny Elaine, Green Andrew J, Bradley Daniel G, Geraghty James G, Bracken Adrian |
|
Protein-truncating variants in moderate-risk breast cancer susceptibility genes: A meta-analysis of high-risk case-control screening studies.
Cancer genetics 2015 Sep 208 (9): 455-63. Aloraifi Fatima, McCartan Damian, McDevitt Trudi, Green Andrew J, Bracken Adrian, Geraghty Jam |
|
A Comparative Analysis of Breast and Ovarian Cancer-related Gene Mutations in Canadian and Saudi Arabian Patients with Breast Cancer.
Anticancer research 2015 May 35 (5): 2601-10. Amemiya Yutaka, Bacopulos Stephanie, Al-Shawarby Mohamed, Al-Tamimi Dalal, Naser Walid, Ahmed Ayesha, Khalifa Mahmoud, Slodkowska Elzbieta, Seth Ar |
|
Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
BMC medical genetics 2014 15 (1): 55. Silva Felipe C, Lisboa Bianca Cg, Figueiredo Marcia Cp, Torrezan Giovana T, Santos Erika Mm, Krepischi Ana C, Rossi Benedito M, Achatz Maria I, Carraro Dirce |
|
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Breast cancer research : BCR 2014 16 (3): R58. Damiola Francesca, Pertesi Maroulio, Oliver Javier, Le Calvez-Kelm Florence, Voegele Catherine, Young Erin L, Robinot Nivonirina, Forey Nathalie, Durand Geoffroy, Vallée Maxime P, Tao Kayoko, Roane Terrell C, Williams Gareth J, Hopper John L, Southey Melissa C, Andrulis Irene L, John Esther M, Goldgar David E, Lesueur Fabienne, Tavtigian Sean |
|
Haplotype analysis of eight genes of the monoubiquitinated FANCD2-DNA damage-repair pathway in breast cancer patients.
Cancer epidemiology 2013 Jun 37 (3): 311-7. Tang Li-Li, Chen Fei-Yu, Wang Hao, Hu Xue-Li, Dai Xu, Mao Jie, Shen Zheng-Tang, Wu Yu-Hui, Wang Shou-Man, Hai Jian, Yan Guo-Jiao, Li Hui, Huang Ju |
|
RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer.
Breast cancer research and treatment 2012 May 133 (1): 111-6. He Min, Di Gen-Hong, Cao A-Yong, Hu Zhen, Jin Wei, Shen Zhen-Zhou, Shao Zhi-Mi |
|
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.
Human mutation 2012 Jan 33 (1): 158-64. Brooks Jennifer D, Teraoka Sharon N, Reiner Anne S, Satagopan Jaya M, Bernstein Leslie, Thomas Duncan C, Capanu Marinela, Stovall Marilyn, Smith Susan A, Wei Shan, Shore Roy E, Boice John D, Lynch Charles F, Mellemkjaer Lene, Malone Kathleen E, Liang Xiaolin, , Haile Robert W, Concannon Patrick, Bernstein Jonine |
|
Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes.
Cancer research 2011 Sep 71 (17): 5792-805. Rebbeck Timothy R, Mitra Nandita, Domchek Susan M, Wan Fei, Friebel Tara M, Tran Teo V, Singer Christian F, Tea Muy-Kheng Maria, Blum Joanne L, Tung Nadine, Olopade Olufunmilayo I, Weitzel Jeffrey N, Lynch Henry T, Snyder Carrie L, Garber Judy E, Antoniou Antonis C, Peock Susan, Evans D Gareth, Paterson Joan, Kennedy M John, Donaldson Alan, Dorkins Huw, Easton Douglas F, , Rubinstein Wendy S, Daly Mary B, Isaacs Claudine, Nevanlinna Heli, Couch Fergus J, Andrulis Irene L, Freidman Eitan, Laitman Yael, Ganz Patricia A, Tomlinson Gail E, Neuhausen Susan L, Narod Steven A, Phelan Catherine M, Greenberg Roger, Nathanson Katherine |
|
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Breast cancer research : BCR 2011 13 (1): R20. Kuusisto Kirsi M, Bebel Aleksandra, Vihinen Mauno, Schleutker Johanna, Sallinen Satu-Lee |
|
RAD50 gene mutations are not likely a risk factor for breast cancer in Poland.
Breast cancer research and treatment 2010 Sep 123 (2): 607-9. Mosor Maria, Zió?kowska-Suchanek Iwona, Roznowski Krzysztof, Baranowska Marta, Januszkiewicz-Lewandowska Danuta, Nowak Jer |
|
Some common mutations of RAD50 and NBS1 in western populations do not contribute significantly to Chinese non-BRCA1/2 hereditary breast cancer.
Breast cancer research and treatment 2010 May 121 (1): 247-9. Cao A-Yong, Hu Zhen, Yin Wen-Jin, Jin Wei, Shao Zhi-Mi |
|
Rad50 c.687delT does not contribute significantly to familial breast cancer in a French population.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Feb 18 (2): 684-5. Uhrhammer Nancy, Delort Laetitia, Bignon Yves-Je |
|
Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Oct 16 (10): 2024-32. Hsu Huan-Ming, Wang Hui-Chun, Chen Sou-Tong, Hsu Giu-Cheng, Shen Chen-Yang, Yu Jyh-Cher |
|
Evaluation of RAD50 in familial breast cancer predisposition.
International journal of cancer. Journal international du cancer 2006 Jun 118 (11): 2911-6. Tommiska Johanna, Seal Sheila, Renwick Anthony, Barfoot Rita, Baskcomb Linda, Jayatilake Hiran, Bartkova Jirina, Tallila Jonna, Kaare Milja, Tamminen Anitta, Heikkilä Päivi, Evans D Gareth, Eccles Diana, Aittomäki Kristiina, Blomqvist Carl, Bartek Jiri, Stratton Michael R, Nevanlinna Heli, Rahman Nazne |
- Page last reviewed:Oct 1, 2020
- Page last updated:Oct 23, 2020
- Content source: